Crinetics Pharmaceuticals (CRNX) Stock Price & Financial Analysis
Crinetics Pharmaceuticals Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Crinetics Pharmaceuticals
What is the current stock price for CRNX?
As of the latest trading session, CRNX stock trades at $35.91. The 52-week range is $25.83–$57.99, with a day range of $35.44–$36.68.
What is the P/E ratio for CRNX?
The P/E ratio (Price-to-Earnings) for CRNX is shown in the Key Statistics section. This valuation metric helps compare Crinetics Pharmaceuticals, Inc. to industry peers.
Does CRNX pay dividends?
Crinetics Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for CRNX?
Based on 10 analysts, the consensus for CRNX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of CRNX?
Crinetics Pharmaceuticals's market capitalization is $3.74B, classifying it as a mid-cap company. Crinetics Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.